Tagged with M

Ireland Gearóid McDermott, director of Amneal Pharmaceuticals’ first site in Ireland down in Cashel, Co. Tipperary, outlines the exciting progress they have made in the past 14 months, the strategic role of the site as Amneal’s first manufacturing facility for inhalation products as Amneal enters the high-value generics space, and his…

Ireland Patsy Carney, co-founder and CEO of EirGen Pharma, tells us the strategy behind their 2015 acquisition by US-based OPKO Health, the highlights of their current transformation from an Irish CDMO business to a center of excellence in R&D and supply chain for the Group, the new sterile, oral solid dose…

Mexico Dr. Marco A. Martinez Rios, General Director of the National Institute of Cardiology in Mexico elaborates on the institution’s rich history in Mexico and its contributions to cardiology through research, teaching and treatment. As the general director of the National Institute of Cardiology, could you introduce yourself to our international…

Philippines Maria Bella Aranas, Country Manager of Glenmark Philippines, discusses the affiliates growing product portfolio in the country and their plans to further expand into different therapeutic areas. She also discusses the impressive performance of the affiliate, which currently is the largest in terms of volume and sales in the Philippines.…

Mexico Andrés Matesanz, general manager at DCS Pharma Mexico, explains how the merger between Dolder and Chemswiss has enlarged the capabilities and the offering of the company in Mexico and showcases the added value of DCS Pharma being considered the fastest option within the industry. ChemSwiss has recently merged with Dolder.…

Singapore With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities for the company, and for the wider life science industry in his capacity as Chairman of APACMed. You have served…

Switzerland The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for global pharmaceutical trends.   Ferring has bundled the European and Canadian markets into one single region. Could you please introduce us to the full scope of your role…

Singapore As the world’s best airport, Changi Airport is also a fast growing hub for pharma freight shipping, and has demonstrated significant leadership in the world of pharma logistics hubs while advancing Changi’s quality standards and end to end service in Singapore.  Changi Airport has recently been recognized as the best…

Mexico José Alberto Peña, managing director at Marzam Mexico, showcases the benefits that distributors can offer to the healthcare and life science sector as well as Marzam’s strategy to overcome the industry challenges in Mexico. After twenty-five years working for some of the most prestigious pharmaceutical companies you accepted in November…

Singapore What role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen attractive, steady, and solid growth across the region since I became the regional president of Evonik Southeast Asia, Australia and…

Singapore In an exclusive interview with Brent Scott, President of Asia for Stryker, he highlights the growth potential of the region, Stryker’s aggressive acquisition strategy, and the strategic partnerships in the region.   I see the most growth prospects in our Medical Surgical Business because much of it is based around…

Mexico Carlos Pérez Muguía, CEO at NYCE, showcases the increasing added value brought by this leading Cofepris’ authorized third party (ATP) to the healthcare industry, the future objectives of the company to enter into the biotech field, and its readiness to continue helping Cofepris in other areas to further strengthen Mexico’s…